Our results suggest that memory CD8 + T cells “remember” tumour antigens, leading to potent immune reactions that suppress tumour regrowth in all challenged animals previously treated with anti-PD-1 and anti-TIGIT antibodies. Here, CD8A is linked to neoplasm.